M Samama

13.4k total citations · 3 hit papers
200 papers, 9.6k citations indexed

About

M Samama is a scholar working on Internal Medicine, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M Samama has authored 200 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Internal Medicine, 83 papers in Hematology and 82 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M Samama's work include Venous Thromboembolism Diagnosis and Management (89 papers), Blood Coagulation and Thrombosis Mechanisms (62 papers) and Atrial Fibrillation Management and Outcomes (54 papers). M Samama is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (89 papers), Blood Coagulation and Thrombosis Mechanisms (62 papers) and Atrial Fibrillation Management and Outcomes (54 papers). M Samama collaborates with scholars based in France, United States and Canada. M Samama's co-authors include Jeffrey I. Weitz, Grigoris Gerotziafas, L. Bara, Céline Guinet, David García, Trevor Baglin, Alain Leizorovicz, C Janbon, Louis Desjardins and Carl‐Gustav Olsson and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

M Samama

197 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1999 1.1k citations M Samama et al. profile →
Parenteral Anticoagulants

2012 721 citations David García, Trevor Baglin et al. CHEST Journal profile →
Parenteral Anticoagulants

2008 518 citations Jack Hirsh, Kenneth A. Bauer et al. CHEST Journal profile →

Peers

Countries citing papers authored by M Samama

Since Specialization

Citations

This map shows the geographic impact of M Samama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Samama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Samama more than expected).

Fields of papers citing papers by M Samama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Samama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Samama. The network helps show where M Samama may publish in the future.

Co-authorship network of co-authors of M Samama

This figure shows the co-authorship network connecting the top 25 collaborators of M Samama. A scholar is included among the top collaborators of M Samama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Samama. M Samama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Parenteral Anticoagulants breakdown → 2012 ·CHEST Journal ·David García, Trevor Baglin, Jeffrey I. Weitz, M Samama	721
2	In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux 2011 ·Thrombosis Research ·M Samama, Jeanne Mendell, Céline Guinet, Léna Le Flem, Satoshi Kunitada	54
3	Laboratory assessment of new anticoagulants 2011 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·M Samama, Céline Guinet	130
4	The Significance of Endothelial Heterogeneity in Thrombosis and Hemostasis 2010 ·Seminars in Thrombosis and Hemostasis ·Hau C. Kwaan, M Samama	22
5	Recommendations on biosimilar low‐molecular‐weight heparins 2009 ·Journal of Thrombosis and Haemostasis ·Job Harenberg, A. K. Kakkar, D. BERGQVIST, T W Barrowcliffe, Benito Casu, Jawed Fareed, Patrick Mismetti, Frederick A. Ofosu, (unknown), M Samama, Sam Schulman	26
6	Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin 2009 ·Thrombosis and Haemostasis ·Grigoris Gerotziafas, Charlotte Dupont, Alex C. Spyropoulos, Mohamed Hatmi, M Samama, (unknown), Ismaı̈l Elalamy	14
7	Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone? 2009 ·Blood Coagulation & Fibrinolysis ·(unknown), M Samama	6
8	Parenteral Anticoagulants breakdown → 2008 ·CHEST Journal ·Jack Hirsh, Kenneth A. Bauer, Maria Benedetta Donati, Michael K. Gould, M Samama, Jeffrey I. Weitz	518
9	Circulating platelet–leukocyte aggregates: A marker of microvascular injury in diabetic patients 2007 ·Thrombosis Research ·Ismaı̈l Elalamy, (unknown), Grigoris Gerotziafas, Anna D. Petropoulou, Françoise Robert, (unknown), F. Elgrably, M Samama, (unknown)	57
10	Effect of the anti‐factor Xa and anti‐factor IIa activities of low‐molecular‐weight heparins upon the phases of thrombin generation 2007 ·Journal of Thrombosis and Haemostasis ·Grigoris Gerotziafas, Anna D. Petropoulou, E Verdy, M Samama, Ismaı̈l Elalamy	90
11	Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma 2004 ·Blood Coagulation & Fibrinolysis ·Grigoris Gerotziafas, François Depasse, Tahar Chakroun, Patrick Van Dreden, M Samama, Ismaı̈l Elalamy	34
12	Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life‐threatening hemorrhage 2002 ·American Journal of Hematology ·Grigoris Gerotziafas, (unknown), (unknown), (unknown), Evdoxia Hatjiharissi, Mary Papaioannou, (unknown), (unknown), M Samama, John Christakis	63
13	Diagnosis And Clinical Characteristics Of Inherited Activated Protein C Resistance 1996 ·Pathophysiology of Haemostasis and Thrombosis ·M Samama, Dietmar Simon, MH Horellou, Marc Trossaërt, Ismaı̈l Elalamy, J Conard	20
14	Factor VII activation and oral contraceptives 1993 ·Thrombosis Research ·Geneviève Plu‐Bureau, (unknown), L. Bara, A Malméjac, L Guize, M Samama	12
15	Factor VII activation and menopausal status 1990 ·Thrombosis Research ·Pierre‐Yves Scarabin, Claire Bonithon‐Kopp, L. Bara, A Malméjac, L Guize, M Samama	46
16	Relationship between Biological Activity and Concentration of a Low-Molecular-Weight Heparin (PK 10169) and Unfractionated Heparin after Intravenous and Subcutaneous Administration 1986 ·Pathophysiology of Haemostasis and Thrombosis ·J. Dawes, L. Bara, (unknown), M Samama	63
17	Partial Reversal of Low Molecular Weight Heparin (PK 10169) Anti-Xa Activity by Protamine Sulfate: In vitro and in vivo Study during Cardiac Surgery with Extracorporeal Circulation 1986 ·Pathophysiology of Haemostasis and Thrombosis ·(unknown), (unknown), L. Bara, (unknown), B. Abry, P. Guibourt, (unknown), (unknown), A Carpentier, M Samama	83
18	Discriminant Study of Platelet Volume Indices in the Etiological Diagnosis of Thrombocytopenia 1984 ·Acta Haematologica ·(unknown), M. Tirmarche, (unknown), (unknown), M Samama	3
19	Fibrinogen and platelet aggregation. Role of the glycopeptidic part and of the fibrinopeptide B 1978 ·Biochemical and Biophysical Research Communications ·J. Soria, Claudine Soria, Olivier F. Bertrand, M Samama	6
20	[MASSIVE THROMBOSIS OF THE VESSELS OF AN EXTREMITY DURING A CONGENITAL HYPOFIBRINEMIA]. 1964 ·PubMed ·G Marchal, G Duhamel, M Samama, Georges Flandrin	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact